C4 Therapeutics (CCCC) PT Lowered to $12 at Stifel
Tweet
Share
E-mailGet Alerts CCCC Hot Sheet
Price: $4.08 +4.62%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Stifel analyst Bradley Canino lowered the price target on C4 Therapeutics (NASDAQ: CCCC) to $12.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Godrej Consumer Products Ltd. (GCPL:IN) PT Lowered to INR1,150 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
